1. Home
  2. LFVN vs PLRX Comparison

LFVN vs PLRX Comparison

Compare LFVN & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

N/A

Current Price

$6.22

Market Cap

78.0M

Sector

Health Care

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

N/A

Current Price

$1.08

Market Cap

69.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFVN
PLRX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
69.7M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
LFVN
PLRX
Price
$6.22
$1.08
Analyst Decision
Buy
Hold
Analyst Count
2
6
Target Price
★ $7.50
$2.67
AVG Volume (30 Days)
33.8K
★ 360.8K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 3.17%
N/A
EPS Growth
N/A
★ 29.97
EPS
★ 0.40
N/A
Revenue
★ $203,204,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.34
N/A
P/E Ratio
$15.80
★ N/A
Revenue Growth
★ 1.86
N/A
52 Week Low
$3.90
$1.02
52 Week High
$11.71
$1.95

Technical Indicators

Market Signals
Indicator
LFVN
PLRX
Relative Strength Index (RSI) 48.79 45.29
Support Level $6.26 $1.02
Resistance Level $6.51 $1.37
Average True Range (ATR) 0.21 0.04
MACD 0.02 -0.01
Stochastic Oscillator 53.71 18.18

Price Performance

Historical Comparison
LFVN
PLRX

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: